Tag: China Biotech
Beijing’s BioGeometry passes $100M to design antibodies from scratch
BioGeometry passed $100 million in Series A funding led by China Life Capital to scale GeoFlow and GeoCell, generative models…
MindRank hands China rights to its AI-designed obesity pill
The Hangzhou biotech gives two 3SBio units exclusive China commercialization for MDR-001 in a deal worth up to RMB 1.75B.
Anew Labs leaves ByteDance with $290M to design drugs with AI
The Shanghai spinout's first outside round values the young company near $1.5B and keeps ByteDance as its largest shareholder.